Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05GPI
|
||||
| Former ID |
DNC007330
|
||||
| Drug Name |
3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C32H39NO3
|
||||
| Canonical SMILES |
CN(CCCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=<br />CC=C4
|
||||
| InChI |
1S/C32H39NO3/c1-33(25-26-16-10-9-11-17-26)22-14-7-5-3-2-4-6-8-15-23-35-27-20-21-29-31(24-27)36-30-19-13-12-18-28(30)32(29)34/h9-13,16-21,24H,2-8,14-15,22-23,25H2,1H3
|
||||
| InChIKey |
GQHNOERJFAPKTD-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2007 Jan 1;15(1):575-85. Epub 2006 Sep 27.Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.